ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
New research labs and process development services to enable next generation therapeutics
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
This office will be the central hub for all operations related to companies ethical pharmaceutical business
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Subscribe To Our Newsletter & Stay Updated
